Cross Country Healthcare (CCRN) awards 35,804 restricted shares to General Counsel

Rhea-AI Filing Summary

Cross Country Healthcare, Inc. reported that its General Counsel and Secretary, Susan E. Ball, received a grant of 35,804 restricted shares of common stock on December 18, 2025 at a stated price of $0. Following this grant, she beneficially owns 211,836 shares directly.

The restricted shares vest in three substantially equal installments on December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee approved the number of restricted shares to be granted on December 18, 2025 instead of March 31, 2025, after the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

Insider Trade Summary

Net Buyer: 35,804 shares

Net Buy 1 txn

Insider Ball Susan E

Role General Counsel and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	35,804	$0.00	$0.00

Holdings After Transaction: Common Stock — 211,836 shares (Direct)

Footnotes (1)

1. F1. These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 12/22/2025 - 07:16 AM Learn about SEC filing dates

FAQ

What insider transaction did CCRN report for Susan E. Ball?

The company reported that Susan E. Ball, its General Counsel and Secretary, received a grant of 35,804 restricted shares of common stock on December 18, 2025.

At what price were the 35,804 restricted shares granted at Cross Country Healthcare (CCRN)?

The 35,804 restricted shares of common stock were granted at a stated price of $0.

How many Cross Country Healthcare shares does Susan E. Ball own after this transaction?

After the reported grant, Susan E. Ball beneficially owns 211,836 shares of Cross Country Healthcare common stock directly.

What is the vesting schedule for Susan E. Ball’s 35,804 restricted shares at CCRN?

The 35,804 restricted shares vest in three substantially equal installments on December 18, 2026, March 31, 2027 and March 31, 2028.

Why was the grant date for Susan E. Ball’s restricted shares set to December 18, 2025?

The Compensation Committee approved the number of restricted shares to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

What position does the reporting person hold at Cross Country Healthcare (CCRN)?

The reporting person, Susan E. Ball, is an officer of Cross Country Healthcare, serving as General Counsel and Secretary.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ball Susan E

(Last) (First) (Middle)

C/O CROSS COUNTRY HEALTHCARE, INC.

6551 PARK OF COMMERCE BOULEVARD, N.W.

(Street)

BOCA RATON FL 33487

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
12/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/18/2025		A		35,804(1)	A	$0	211,836	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted shares of common stock ("RSAs") vest in three substantially equal installments on each of December 18, 2026, March 31, 2027 and March 31, 2028. The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025. After the initial vesting date 12 months from the grant date, the remaining RSAs will vest on March 31 of the two subsequent years to coincide with the vesting dates of the Company's previously granted RSAs.

	/s/ Susan E. Ball	12/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.